Apr 23 |
PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
|
Mar 30 |
PDS Biotechnology Corporation's (NASDAQ:PDSB) market cap dropped US$1.5m last week; individual investors who hold 59% were hit as were institutions
|
Mar 28 |
PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
|
Mar 28 |
Q4 2023 PDS Biotechnology Corp Earnings Call
|
Mar 27 |
PDS Biotechnology Corporation (PDSB) Q4 2023 Earnings Call Transcript
|
Mar 27 |
PDS Biotechnology Corp (PDSB) Reports Full Year 2023 Financial Results and Clinical Strategy Update
|
Mar 27 |
PDS Biotechnology GAAP EPS of -$1.39 beats by $0.06
|
Mar 27 |
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
|
Mar 27 |
Earnings Scheduled For March 27, 2024
|
Mar 26 |
PDS Biotechnology FY 2023 Earnings Preview
|